Refractory Ascites in Liver Cirrhosis

Area of Science:

• Hepatology
• Nephrology
• Gastroenterology

Background:

• Ascites is a frequent complication of liver cirrhosis, affecting approximately 10% of patients who develop refractory disease.
• Refractory ascites results from complex pathogenetic factors leading to renal hypoperfusion and sodium retention, often causing renal dysfunction.
• Management of refractory ascites is challenging due to diuretic resistance and the need for interventions to prevent complications.

Purpose of the Study:

• To review the management strategies for refractory ascites in liver cirrhosis.
• To highlight the association between refractory ascites and renal dysfunction.
• To discuss the role of liver transplantation in managing refractory ascites and associated renal impairment.

Main Methods:

• Review of current literature and clinical guidelines for refractory ascites management.
• Discussion of therapeutic options including large volume paracentesis, albumin infusion, and transjugular intrahepatic portosystemic shunt (TIPS) insertion.
• Evaluation of the impact of liver transplantation on refractory ascites and renal function.

Main Results:

• Large volume paracentesis with albumin infusion is a primary treatment for symptomatic relief and prevention of circulatory dysfunction.
• Transjugular intrahepatic portosystemic shunt (TIPS) is a viable option for select patients with good liver reserve, potentially improving nutritional status.
• Liver transplantation is the definitive treatment for patients with refractory ascites and significant liver or renal dysfunction, often leading to improvement in renal function post-transplant.

Conclusions:

• Refractory ascites management requires a multi-faceted approach, including adherence to sodium restriction, paracentesis, and consideration of TIPS.
• Renal dysfunction is a common comorbidity that frequently improves after liver transplantation.
• Liver transplantation offers the best long-term solution for patients with refractory ascites and advanced liver disease or renal impairment.